Clinical trial INCB 01158-203
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of INCB001158 in Combination With Chemotherapy, in Subjects With Advanced or Metastatic Solid Tumors. (INCB01158-203)
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1 |
Academic trial | Non |
Sponsor | Incyte Corporate |
EudraCT Identifier | 2017-002904-29 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03314935 |
Inclusion criteria | Metastatic Biopsy mandatory |
Last update |